Zinc is an essential trace mineral your body requires for immune function, wound healing, and numerous enzymatic processes, formally recognized as essential to human nutrition in the 1960s. Zinc's specific popular application — treating the common cold — emerged from a deliberately designed clinical hypothesis in the 1980s, based on zinc's role in immune function and its ability to interfere with rhinovirus replication in laboratory studies.
This targeted origin has produced one of the more genuinely well-studied and consistently replicated evidence bases in this Atlas for a specific, narrow application.
Zinc has real, well-replicated evidence for shortening the duration of an already-present common cold — though notably not for preventing colds. A meta-analysis of 17 RCTs (2,121 participants) found zinc significantly shortened cold symptom duration compared to placebo. More specific research on high-dose zinc acetate lozenges strengthens this further: an individual patient data meta-analysis found zinc lozenge users recovered 3.1 times faster, with 70% recovered by day five compared to just 27% on placebo.
A comprehensive 2024 Cochrane review confirms this precise pattern: zinc "may have little or no effect on the prevention of colds but may reduce the duration of ongoing colds." This consistent, well-differentiated finding — real benefit for treatment, no benefit for prevention — replicated across multiple independent meta-analyses including a recent Cochrane review, is why "Moderate-Strong" is the accurate rating for this specific, narrow application.
Not applicable in the traditional herbal sense — obtained through diet or taken as a mineral supplement in lozenge, tablet, or syrup form.